Biomeme Inc.

Biomeme develops mobile molecular diagnostics designed to bring laboratory-quality testing beyond traditional lab settings. Its platform serves three areas: CBRN biodefense, healthcare, and proactive wellness. For military personnel, first responders, and government agencies, Biomeme offers field-deployable tools for detecting biological threats and supporting real-time biosurveillance. In healthcare, its host-response testing is designed to help characterize infection type and progression, including applications related to antimicrobial resistance and stewardship. For wellness, the company offers molecular testing to monitor gene expression, peptide therapy response, longevity-related measures, and athletic performance.

Biomeme’s products include the Biomeme/5, a next-generation system featuring isothermal amplification, enhanced multiplexing, and results in 15 minutes or less, and the Franklin ISP, a rugged, portable real-time PCR thermocycler. The Franklin supports open-architecture Go-Strips assays and can deliver results in under an hour. Biomeme also provides scientific resources, platform information, and partnership support for pharmaceutical companies, researchers, and organizations seeking mobile molecular testing solutions. Its mission is to make biological insight accessible wherever it is needed.